On September 11, 2017, Medical Readiness awarded a Pharmaceutical contract to Alvogen, Inc. for fourteen (14) product lines

On September 11, 2017, DLA Troop Support awarded a new contract SPE2D0-17-D-0008 to Alvogen Inc under Open Season Solicitation SPE2D0-15-R-0002. This is an Indefinite Delivery-Indefinite Quantity (IDIQ) fixed price type contract with Economic Price Adjustment (EPA) clauses for various Pharmaceutical products in support of the Corporate Exigency Contracts (CEC) program. The contract is for ten years (one-year base, with the option to extend the contract for nine (9), one -year term option periods). The Pharmaceutical CEC Program establishes partnerships between the Department of Defense (DOD) and industry to ensure that the industrial base is prepared to respond to the Military Services increased demand for items designated as critical during times of mobilization, war, contingency and military operations. This contract purchases access for various pharmaceutical product line items.